Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation  by Castellá, Manuel et al.
Castella´ et al Acquired Cardiovascular DiseaseThoracoscopic pulmonary vein isolation in patients with atrial
fibrillation and failed percutaneous ablationManuel Castella´, MD, PhD, Daniel Pereda, MD, Carlos A. Mestres, MD, PhD, FETCS, Fe´lix Go´mez, MD,
Eduard Quintana, MD, and Jaume Mulet, MD, PhDFrom th
Univ
Disclos
outco
Manu
Receive
publi
Address
gery,
clinic
0022-52
Copyrig
doi:10.1
A
C
DObjective: Pulmonary vein isolation is indicated in patients with symptomatic isolated atrial fibrillation not con-
trolled with antiarrhythmic therapy. We describe our surgical experience with thoracoscopic pulmonary vein iso-
lation in patients in whom percutaneous ablation has failed.
Methods: Thirty-four adult patients with unsuccessful catheter ablations (range 1–4, mean 2  1) underwent
thoracoscopic bipolar-radiofrequency pulmonary vein isolation. Seventeen patients had paroxysmal atrial fibril-
lation, 12 with persistent and 5 with long-standing persistent fibrillation, for a mean of 6 years (range 3–10 years),
13 years (5–25 years), and 9 years (3–15 years), respectively.
Results: There was no mortality during the procedure or follow-up (mean 16 11 months). Two patients needed
conversion to thoracotomy owing to hemorrhage, and ablation could not be completed. Antiarrhythmic therapy
was withdrawn 3 months postoperatively. Postoperative sinus rhythm was maintained in 82% of those with par-
oxysmal atrial fibrillation (13/15 at 6 months, 9/11 at 12 months), 60% had persistent atrial fibrillation (8/12 at 6
months and 6/10 at 12 months), and 20% had long-standing persistent atrial fibrillation (1/5 at 6 and 12 months).
Preoperative left atrial diameter significantly differed between patients with paroxysmal fibrillation (mean 42 6
mm) and those with persistent and long-standing persistent fibrillation (means 50 4 and 47 2 mm). Left atrial
size greater than 45 mm and atrial fibrillation type were preoperative factors that significantly influenced outcome
in the univariate logistic regression analysis.
Conclusions: Thoracoscopic pulmonary vein isolation in patients with previously unsuccessful catheter ablations
demonstrates satisfactory sinus rhythm maintenance rates in paroxysmal and persistent atrial fibrillation, but not
in long-standing persistent atrial fibrillation. As with other minimally invasive surgical techniques, there is an im-
portant learning curve. (J Thorac Cardiovasc Surg 2010;140:633-8)In the latest consensus guidelines on atrial fibrillation (AF)
therapy by the American College of Cardiology (ACC),
the American Heart Association (AHA), and the European
Society of Cardiology (ESC), published in 2006, catheter-
based pulmonary vein isolation is a good treatment choice
in patients with paroxysmal symptomatic AF not controlled
with antiarrhythmic drugs or in patients with recurrent per-
sistent AF if they remain symptomatic with rate control ther-
apy.1 These recommendations were based on the knowledge
that most of the trigger zones that originate AF can be found
in the left atrium around the pulmonary veins,2 and by the
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The Journal of Thoracic and Caradiofrequency isolation of the left atrium at the antrum of
the pulmonary veins. In 2007, the Heart Rhythm Society
(HRS), European Heart Rhythm Association (EHRA), and
European Cardiac Arrhythmia Society (ECAS) Task Force
on Catheter and Surgical Ablation of AF developed an Ex-
pert Consensus Statement extending ablation indications to
all symptomatic AF refractory or intolerant to antiarrhyth-
mic medication and, in rare clinical situations, as first-line
therapy.3 It is important to mention that these guideline algo-
rithms focus only on catheter ablation when referring to iso-
lated AF treatment, with no mention of surgical ablation
strategies. Nevertheless, percutaneous ablation is curative
in around 70% to 80% of patients with paroxysmal AF
and normal left atrial size. The incidence of major complica-
tions remains at 5%.4 Success rates drop in patients with
persistent AF, long-standing persistent AF, or an enlarged
left atrium. There is much speculation why catheter ablation
is not fully successful. First, there is the technologic issue of
achieving complete isolation. Gaps created when perform-
ing a line of endocardial ablation dots likely affect success
rates. This effect is increased in enlarged atria, where lines
need to be longer. Often, to avoid atrial perforation and
transesophageal fistulas, the amount of energy applied dur-
ing the procedure must be limited. In addition, the left atrialrdiovascular Surgery c Volume 140, Number 3 633
TABLE 1. Preoperative characteristics of the 32 patients with
complete ablation procedure
Mean Median SD Range
Age (y) 54 56 8.62 28–66
AF duration (y) 8.10 7.00 4.84 2–25
Number of previous
percutaneous procedures
2.06 2.00 0.91 1–4
Left atrial size (mm) 45.34 45.50 5.61 32–54
SD, Standard deviation; AF, atrial fibrillation.
Abbreviations and Acronyms
AF ¼ atrial fibrillation
AUC ¼ area under the curve
CI ¼ confidence interval
IVC ¼ inferior vena cava
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Dwall thickness can vary from patient to patient. All of these
factors can affect success rates. It is therefore possible that
lines can be incomplete when drawn during a percutaneous
procedure in which a closed approach is used and visualiza-
tion is limited. In addition, myocardial remodeling and fibro-
sis that can occur in patients with an enlarged atrium and
persistent or long-standing persistent AF may necessitate
more than isolation of possible trigger zones around pulmo-
nary veins. These types of patients need to be more focused
toward a true maze approach owing to myocardial remodel-
ing and fibrosis.
The possibility of curing paroxysmal AF by pulmonary
vein isolation combined with new energy sources has led
to newer types of surgical strategies focused on minimally
invasive procedures.5 Current surgical devices are able to
deliver radiofrequency energy via gold-plated electrodes
placed around the pulmonary veins. These clamps produce
a consistent line of ablation. Most important, transmurality
can be confirmed by a fall in electrical conductance along
the tissue ablated.
This study reports our experience with symptomatic pa-
tients with AF in whom repetitive percutaneous pulmonary
vein ablation has failed. Our purpose was to surgically en-
sure transmural ablation lines in these patients, to confirm
that percutaneous catheter ablation failures were due to de-
fects in pulmonary vein isolation and to evaluate whether
persistent and long-standing persistent AF are influenced
by pulmonary vein isolation alone.PATIENTS AND METHODS
From May 2005 to September 2008, 34 patients were selected for thor-
acoscopically assisted pulmonary vein isolation according to the following
criteria: symptomatic AF that did not respond to medical therapy and failure
to eradicate the arrhythmia by percutaneous radiofrequency ablation of the
left atrium. All patients had one or more of the following symptoms before
surgery: palpitations, shortness of breath at high cardiac rates, and anxiety
for the possibility of a symptomatic AF episode. Patterns of percutaneous
monopolar radiofrequency lesions in the preoperative catheter ablations in-
cluded pulmonary vein ablation in all patients. The ablation lines ran be-
tween the left and right pulmonary veins, between the left inferior
pulmonary vein and the mitral annulus, and between the inferior vena
cava (IVC) and the tricuspid annulus in most patients (preoperative data
in Table 1). Percutaneous ablations were performed a mean of 2 times,
with a range from 1 (10 patients) to 4 times (1 patient). Entrance and exit
blocks were confirmed after each percutaneous ablation and were required
to be considered successful in all procedures and all patients. Nevertheless,
all patients continued to have their AF pattern for at least 3 months after the
percutaneous ablation, except 3 patients in whom the endoluminal treatment634 The Journal of Thoracic and Cardiovascular Surgtransformed their pattern from persistent to paroxysmal. Three patients had
perforation of the left atrium during percutaneous ablation, and 1 patient
with persistent AF needed emergency sternotomy to control bleeding.
The patient was treated with surgical ablation during that sternotomy.
This was the only patient in whom the surgical access was not thoraco-
scopic. In another patient with a history of atrial bleeding during percutane-
ous ablation necessitating emergency subxiphoid drainage, important
pericardial adhesions were detected at surgery 6 months later. A 28-year-
old patient had asymptomatic severe stenoses of the left pulmonary veins
from the first ablation performed with the lasso technique 6 years before
the operation.6 These stenoses produced a hemodynamic gradient of 16
mm Hg (2 m/s) through the narrowest points of the superior and inferior
veins at the entrance to the left atrium, 4.8 and 5.8 mm in diameter, respec-
tively, compared with 19.8 and 18.7 mm in the right side. Last, another pa-
tient had Fontaine grade IIa inferior limb ischemia owing to a femoral
arteriovenous fistula after puncture for percutaneous ablation that needed re-
constructive vascular surgery 1 week after thoracoscopic pulmonary vein
isolation.
All patients had isolated AF, without any history of coronary artery or
valvular disease. Sixteen (47%) of 34 patients were treated for arterial hy-
pertension, which was well controlled in all of them. Preoperative echocar-
diogram showed normal function of the left and right ventricles in all
patients except for one with severe left ventricular dysfunction attributed
to tachycardiomyopathy (left ventricular ejection fraction 35%, no segmen-
tal contraction deficits, and repetitive negative stress tests). No valvular dys-
functions were detected, nor were there any thrombi in the left atrial
appendage. Left atrial diameter was significantly smaller in the patients
with paroxysmal AF as opposed to those with persistent and long-standing
persistent AF (42  6 mm vs 50  4 mm, respectively; P<.02). Although
time from AF initiation did not significantly differ between the types of AF
patterns, patients with paroxysmal AF had less time from first episodes until
surgery (Table 1). There were no differences in age or prevalence of arterial
hypertension, known factors favoring AF.7
Procedural Technique
All patients except one were operated on through video-assisted thoraco-
scopic surgery. The one exception, with persistent AF, needed emergency
surgery after left atrial perforation and cardiac tamponade in the electro-
physiology laboratory, so the procedure was performed through a sternot-
omy after the left atrium had been sutured.
In the video-assisted surgery, the procedure was conducted after general
anesthesia and double-lumen endotracheal intubation. The patient was
placed in the left lateral decubitus position to access the right pulmonary
veins through two 5-mm ports in the sixth intercostal space and a 50-mm
working port in the third, with the use of a soft tissue retractor (Edwards
Lifesciences CardioVations, Irvine, Calif), as described previously.5 After
lung deflation, the pericardium was divided 2 cm anterior to the phrenic
nerve from the superior vena cava to the IVC, with the visual help of
a 30, 5-mm thoracoscope. Blunt dissection was used to access the oblique
sinus between the right inferior pulmonary vein and the IVC, and both right
pulmonary veins were surrounded with the help of an articulated lightedery c September 2010
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Ddissector (AtriCure, Inc, Cincinnati, Ohio). A Red Rubber catheter was
placed around the pulmonary veins. A 5-cm long bipolar radiofrequency
clamp (AtriCure) was advanced with the rubber catheter attached to the
tip of the lower jaw to guide it through the oblique sinus, until its tip could
be visualized cephalic to the superior pulmonary vein. Bipolar ablation was
accomplished by closing the bipolar clamp along a left atrial cuff adjacent to
the entrance of the pulmonary veins, ensuring not to ablate the veins. The
clamp produces a linear thermal lesion by radiofrequency energy, and trans-
murality was accomplished when tissue conductance dropped under 0.0025
siemens, normally after 8 to 15 seconds of energy delivery. After testing for
transmurality as specified below, the lung was reinflated, a chest tube was
inserted through one of the small ports, and the other thoracic accesses
were closed. The patient was then placed in the right lateral decubitus posi-
tion to access the left pulmonary veins and the left atrial appendage.
Placement of thoracoscopic ports on the left side was similar to the right.
After division of the ligament of Marshall, both left pulmonary veins were
surrounded by a Red Rubber catheter with the help of the articulated lighted
dissector. The rubber catheter was used to guide the radiofrequency clamp
to be able to isolate a left atrial cuff surrounding the entrance of the pulmo-
nary veins. Once isolation was completed, the left atrial appendage was sta-
pled and excised with an automatic suture (ETS-Flex 45;Ethicon
Endosurgery Inc, Cincinnati, Ohio).
Ablation lesions are repeated 3 to 5 times on each side to widen the iso-
lation line. Before and after ablation, measurements of isolation were per-
formed by pacing within the pulmonary veins (exit block) and with
ganglionic plexi stimulation. Patients in AF were cardioverted to sinus
rhythm for these measurements. Ganglionic plexi isolation was tested by
stimulation of the ganglionic zones around the pulmonary veins and at
Waterston’s groove at a rate of 1000 bpm and an impulse amplitude of 18
volts (Oscor External pacemaker 203H; Oscor Inc, Palm Harbor, Fla) to
check for sudden bradycardia, as described previously.8 When cardiover-
sion was not successful, atrial electrical activity within the pulmonary veins
(entrance block) and ganglionic plexi activity were measured.
Follow-up protocol included physical examination at the first, third, and
sixth months after the procedure, 24-hour Holter monitoring between the
fourth and sixth months and also at 1 year, and echocardiograms at 6
months. Success was defined as no symptomatic episodes of arrhythmia
or no supraventricular arrhythmia lasting for more than 30 seconds in any
electrocardiographic or Holter measurements. Preoperative antiarrhythmic
therapy was maintained during follow-up in all patients postoperatively. Af-
ter 3 months, antiarrhythmic drugs were suppressed except in patients with
b-blocker therapy. Oral anticoagulation was maintained in the first 6 months
to 1 year after the procedure and then withdrawn if there was no recurrence
of AF, assuming that both the physician and the patient were in agreement.TABLE 2. Results
Results
Peroperative or follow-up mortality 0
Hospital stay (d) 6 (range, 4–15)
SPC 32/34 patients (94%)
Need for extracorporeal circulation 1 (3%)
Free from AF at 6 mo (SPC) 22/32 patients (69%)
Paroxysmal 13/15 patients (87%)
Persistent 8/12 patients (67%)
Long-standing persistent 1/5 patients (20%)
Free from AF at 12 mo (SPC) 16/26 patients (62%)
Paroxysmal 9/11 patients (82%)
Persistent 6/10 patients (60%)
Long-standing persistent 1/5 patients (20%)
Off oral anticoagulation at 12 mo 10/26 patients (63%)
SPC, Surgical procedure completed; AF, atrial fibrillation.Statistical Analysis
Besides application of standard descriptive statistics, a predictive logistic
regression model was built to calculate the probability of success or failure
of the procedure with respect to several preoperative factors. We had the fol-
lowing strategy to select the variables that should be included in our model:
First, univariate logistic regression was used to analyze the influence of all
preoperative factors on outcome after the intervention.9 We selected for the
multivariate analysis all the variables that produced estimations with a P
value<.40. Then, to select our final model we followed the strategy of an-
alyzing all the possible resulting equations evaluating all combinations of
the previously selected predictors and all first-degree interactions between
them to evaluate confusion. All models were constructed according to the
hierarchical principle. We evaluated 3 different adjustment measurements
to select the best model: Mallows’ Cp criteria adapted for logistic regres-
sion,9 the area under the curve (AUC), and the likelihood ratio. For the se-
lected final model, both sensitivity and specificity were calculated as well as
the 95% confidence interval (CI) for the AUC estimation using the receiver
operating characteristic procedure.
All data are expressed as mean  standard deviation.The Journal of Thoracic and CaRESULTS
Before surgical ablation, measurements of pulmonary
vein isolation showed that all patients had either one or
both sides electrically connected to the heart, meaning that
percutaneous ablation had been unsuccessful. After per-
forming 3 ablation lines with the bipolar radiofrequency
clamp, trying to reach as much atrial tissue as possible, we
again tested for isolation. If isolation was not totally ensured,
up to 5 new ablation lines were performed with the help of
the bipolar clamp or the transpolar radiofrequency pen
(Transpolar ablation pen, AtriCure). We ensured transmural-
ity by exit block in all patients with paroxysmal and persis-
tent AF and in 1 patient with long-standing persistent AF.
Entrance block was confirmed in the patients with long-
standing persistent AF that could not be cardioverted. No
ganglionic plexi stimulation was achieved after pulmonary
vein isolation in any patient. In 28 (87.5%) of 32 patients,
isolation was complete after the first round (3 ablations).
In 4 patients we needed to perform 5 ablations on one of
the sides to complete isolation. Procedural times ranged
from 3 to 5 hours.
Follow-up is 100% complete and included physical ex-
amination, Holter monitoring, and echocardiography.
Mean follow-up was 16 11 months (range, 6–45 months).
There was no mortality during the procedure or follow-up
(Table 2). Bilateral pulmonary vein isolation was completed
in all except 2 patients with paroxysmal AF. In these pa-
tients, atrial bleeding required conversion to open right tho-
racotomy. One patient required extracorporeal circulation by
femoral access to control hemorrhage, after bleeding from
the IVC could not be controlled by hemostatic 4-0 polypro-
pylene (Prolene; Ethicon, Inc, Somerville, NJ) stitches. Only
right pulmonary vein isolation was performed in these pa-
tients and both remained in paroxysmal AF during follow-
up. Atrial bleeding in both cases was due to an atrial lesion
caused by cautery, attributed to our learning curve in this
procedure. These patients were the only ones who required
blood transfusion in the operating room, 2 and 4 units ofrdiovascular Surgery c Volume 140, Number 3 635
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Dblood, respectively. No bleeding was caused by repeated ab-
lation although we limited application of bipolar radiofre-
quency to 5 times per side.
One patient, with persistent AF and a history of severe
chronic obstructive pulmonary disease owing to smoking
and 15 years of continuous amiodarone intake, required
postoperative mechanical ventilatory support for 2 days.
All other patients were extubated in the operating room.
No other postoperative complications were registered in
any patient. Mean hospital stay was 6 days (range, 4–15
days). The patient with prolonged ventilatory support and
preoperative persistent AF was readmitted 4 weeks after sur-
gical intervention because of sudden episodes of pain and
dyspnea. Echocardiography and a 64-slice computed tomo-
graphic angiographic scan showed normal ejection fraction
with no signs of pulmonary vein stenosis, pulmonary embo-
lism, or cardiac tamponade. He was discharged home in bet-
ter condition after 10 days and after the initiation of
nonsteroidal anti-inflamatory therapy.
One patient with a history of persistent AF had a stroke 3
days after surgery. This patient had a residual superior left
quadrantanopsia. Inasmuch as this patient had maintained si-
nus rhythm since surgery, with no anticoagulation or antiag-
gregation therapy, we changed our protocol to complete
anticoagulation with intravenous sodium heparin 12 hours
after the operation. The fourth patient on this protocol had
a left chest wall hematoma and hemothorax 48 hours after
the operation and 24 hours after removal of the chest tube,
requiring blood transfusion (2 units of red cells), thoraco-
scopic drainage, and revision. This patient was the only
one requiring blood transfusion in the postoperative period.
Since then, our protocol includes exclusion of oral anticoa-
gulation 2 days before surgery, administering aspirin 100
mg, and restarting oral anticoagulation 24 hours after sur-
gery. With this protocol, we have had no additional intrao-
perative or postoperative cases of bleeding or stroke.
Supraventricular arrhythmias has been eradicated in 82%
of patients with preoperative paroxysmal AF at 1 year’s fol-
low-up, excluding the 2 patients in whom the procedure was
not completed (9/11). Sixty percent of patients with a history
of persistent AF have maintained sinus rhythm postopera-
tively (6/10). Only 1 of the 5 patients in the long-standing
persistent AF group was able to maintain sinus rhythm post-
operatively.
In patients considered to be without AF recurrence, sinus
rhythm was recorded in all physical examinations after a 3-
month window after the operation; there was no trace of AF
or flutter in any of the 24-hour Holter studies and patients re-
ported no recurrence of their symptomatic arrhythmia, either
palpitations or symptoms of heart failure. All patients were
free of AF at 1 year (62%, 16/26) and reported better quality
of life in the postoperative visits. They reported that they
were less anxious. They were successful at switching from
oral anticoagulation to platelet antiaggregation, which could636 The Journal of Thoracic and Cardiovascular Surgbe achieved in 10 patients at 1 year after the operation. Nev-
ertheless, the patient with quadrantanopsia continues to have
several problems related to normal life activities, such as
driving motor vehicles. Interestingly, some patients reported
some of the same symptoms of discomfort that initiated AF
before the operation, lasting for a few seconds at a time, but
with no continuation to any supraventricular arrhythmia. Pa-
tients that remained in AF at 1 year reported no change in
quality of life after the operation.
Four patients in the persistent AF group in whom AF con-
tinued for more than 3 months after surgery returned to the
Electrophysiology Laboratory. Two of them had a change
of pattern to left flutter, and 2 continued to have persistent
AF. In all of them the pulmonary vein isolation performed
during surgery was confirmed in the electrophysiology lab-
oratory. In 1 patient with left atrial flutter, flutter was abol-
ished and changed to sinus rhythm by performing a line
between the right and left pulmonary veins, suggesting
that the flutter pattern was generated by an electrical impulse
going around one of the isolated areas. In the other 3 pa-
tients, no specific sources of arrhythmia were found within
the multiple scars of the left atrium from prior ablations.
Nevertheless, new lines were performed, with absence of
late sinus rhythm.
As explained in the statistical part of the Methods section,
a predictive logistic regression model was built to calculate
the probability of success or failure of the procedure with re-
spect to several preoperative factors. The univariate logistic
regression analysis showed that left atrial diameter greater
than 45 mm and AF type were the only statistically signifi-
cant factors influencing success or failure (Table 3). Interest-
ingly, the number of previous percutaneous ablations did not
affect results. Neither gender nor age influenced the results.
As described in the Methods section and using the results
from the univariate analysis, we selected the multivariate lo-
gistic regression model containing 3 variables that produced
the best estimations of the adjustment criteria: left atrial size
greater than 45 mm, nonparoxysmal AF, and more than 5
years in AF. Besides the statistical properties of the vari-
ables, we chose these variables because of their simplicity
and because of the exactitude in their quantification. The
calculated AUC using the receiver operating characteristic
procedure for the model was 0.795 (95% CI, 0.633–0.958;
P¼ .008), which allows a sensitivity of 70% and specificity
of 81.8%. This model predicts an estimated risk of failure of
surgical pulmonary vein isolation of 2.85% if no risk factor
is present (95%CI, 0.2–29.46). When all factors are present,
the estimated risk of failure reaches 62% (95% CI, 33.88–
84.28) (Table 4). The relative risks of all possible patterns
are shown in Table 5.
DISCUSSION
Our study corroborates prior knowledge that paroxysmal
AF can be controlled by pulmonary vein isolation. For this toery c September 2010
TABLE 3. Univariate logistic regression analysis. Odds Ratio (OR) for failure
95% CI
OR Low High P value
Left atrial
size (mm)
>45 vs 45 7.00 1.185 41.359 .019
AF type All other
vs paroxysmal
5.778 0.987 33.828 .035
Gender Male vs female 1.583 0.0221 11.361 .652
Duration of AF (y) 5 vs<5 5.143 0.547 48.365 .102
Previous percutaneous procedures 2 vs 1 1.333 0.267 6.653 .724
>2 vs 2 1.167 0.251 5.413 .844
Age (y) 60 vs<60 2.267 0.453 11.349 .322
CI, confidence interval; AF, atrial fibrillation.
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surgical, must ensure linearity and transmurality along the
lesions. We performed a consistent ablation line that was
documented to be transmural in the left atrium along the an-
trum of the pulmonary veins, eradicating paroxysmal AF.
Inasmuch as our patients had multiple previous percutane-
ous radiofrequency ablations to isolate pulmonary veins,
our results suggest that percutaneous ablation may not be to-
tally effective at isolating pulmonary veins in some patients.
The ineffectiveness of percutaneous ablation in patients with
a left atrium larger than 45 mm may be due to long ablation
lines, increasing the probability of leaving gaps along the
dot-by-dot endocardial ablation lines. Also, possible failures
may be due to increased myocardial thickness, which may,
in turn, prevent endocardially applied monopolar radiofre-
quency from being transmural. In our opinion, our patients
had incomplete vein isolation before surgery, and this was
completed by bipolar radiofrequency. Our first conclusion
is that failure of percutaneous ablation does not necessarily
mean failure in the strategy therapy of pulmonary vein iso-
lation in patients with paroxysmal AF.
Our results in patients with persistent AF are not so clear.
Although a 60% success rate is not a failure in treatment, un-
doubtedly this shows that pulmonary isolation is not enough
in a significant percentage of these patients. This may be due
to other factors influencing the permanence of this arrhyth-
mia. Our multivariate logistic regression model indicates
that an effective pulmonary vein isolation, such as surgicalTABLE 4. Estimated risk of failure depending on predictive factors
Risk patterns Risk (95% CI)
No risk factors present 2.85% (0.2–29.46)
Isolated risk factors
Left atrial size>45 mm 9.42% (0.35–75.39)
Nonparoxysmal AF 7.51% (0.35–65.34)
>5 y with AF 14.46% (3.20–46.36)
All risk factors present 62.37% (33.88–84.28)
CI, 95% confidence interval for the estimation of the probability of failure of the pro-
cedure depending on the presence of preoperative risk factors predicted by our multi-
variate logistic regression model; AF, atrial fibrillation.
The Journal of Thoracic and Cabipolar radiofrequency is able to achieve, has between
a 7% and a 15% chance of failure when AF is not paroxys-
mal, left atrial diameter reaches 45 mm, or in patients with
a history of AF lasting more than 5 years. Moreover, results
are prohibitive when these 3 factors combine.
Most of the patients with persistent and long-standing per-
sistent AF had a history of paroxysmal AF, so that the initial
value of triggering zones around the pulmonary veins may
have been an important factor in the past. However, the es-
tablishment of electrical re-entrant circuits in these enlarged
and more fibrotic atria probably changes the atrial substrate,
favoring the chronicity of AF and overriding the importance
of the triggering factors that initially imposed AF. This is
possibly why procedures designed to block re-entrant cir-
cuits, such as the Cox maze operation, are more successful
in persistent and long-standing persistent AF. Previous re-
ports of radiofrequency pulmonary vein isolation alone in
patients with long-standing AF have reported between
25% and 72% success in recovering stable sinus
rhythm.10,11 The 20% success rate in our subgroup of pa-
tients with repetitive failed catheter ablation further rein-
forces the idea that pulmonary vein isolation alone may be
insufficient in long-standing persistent AF. Indication of per-
cutaneous or minimally invasive ablation procedures solely
involving pulmonary veins in this type of patient is contro-
versial and needs to be in consensus with the patient, inas-
much as it involves trading minimal invasiveness for
a lesser chance of success. Percutaneous endocardialTABLE 5. Relative risk of all possible patterns
Left atrial
size (mm)
Preoperative
arrhythmia
Duration of
AF (y) 45 mm (RR) >45 mm (RR)
Paroxysmal <5 y 1.00 3.30
5 y 5.07 13.15
Other <5 y 2.63 7.84
5 y 11.18 21.89
RR, Relative risk of failure of all possible combinations of preoperative factors com-
pared with the lowest risk model with no risk factors present; AF, atrial fibrillation.
rdiovascular Surgery c Volume 140, Number 3 637
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by connecting lines to the mitral annulus or by isolating
the posterior wall of the left atrium in what has been named
the ‘‘box lesion.’’ However, despite the latest technology,
percutaneous ablation proves to be an aggressive therapy
with a 50% success rate in moderately enlarged left atria.
The incidence of major complications is 5%.4,6
Patients in this study represent our initial experience in
thoracoscopic AF therapy. In our opinion, success rates re-
garding freedom from AF in this series were not affected
by our reduced exposure to this operation. Not only does
our group routinely use bipolar radiofrequency for AF treat-
ment through sternotomy, but the device used ensures
a transmural linear lesion of the tissue clamped, with mini-
mal surgeon-induced variability. To further ensure trans-
murality, we performed tests of isolation and repeated the
procedure up to 5 times on each side until isolation was con-
firmed. Results for maintenance of sinus rhythm were simi-
lar from the earlier to the later patients when matched for AF
type. However, a learning curve had to be surpassed for sur-
geons not familiar with thoracoscopy. Operating times have
ranged from 5 hours initially to 3 hours in the last 10 pa-
tients. Most important, we could not complete the ablation
procedure in 2 patients owing to bleeding from the right
atrium that became severe after we tried to repair it thoraco-
scopically. Urgent cardiopulmonary bypass through femoral
access was required in 1 patient. Additionally, we had to
change our anticoagulation and antiaggregation protocols
after a patient with no antiaggregation or anticoagulation
had a minor stroke, and he was followed by another patient
with a hemothorax caused by an excess of anticoagulation
emphasis on our part. We would like to bring a word of cau-
tion to surgeons entering thoracoscopic AF therapy. In an
operation in which morbidity is not expected, 1 peroperative
death has been reported.12 However, we believe thoraco-
scopic pulmonary vein isolation is a good alternative to per-
cutaneous catheter ablation for paroxysmal AF, inasmuch as
the results published for both techniques support minimally
invasive surgery. The rates of major complications do not fa-
vor one technique over the other.4,5,7
Study Limitations
We acknowledge that this is a report with few patients, but
in our opinion it indicates important differences in results of
both catheter and thoracoscopic ablation. More series are
needed to confirm this, preferably randomized studies com-
paring both techniques. A possible factor that needs to be
considered with larger studies and clinical trials is the possi-
bility of missing arrhythmias during follow-up, including
the use of transtelephonic monitoring, which of course
may not always be available, to rule out asymptomatic AF
recurrences. Patients in this study are a highly selected group
in whom catheter ablation failed, with a high incidence of
major complications. Nevertheless, we wish to highlight638 The Journal of Thoracic and Cardiovascular Surgthat this is a small population from an experienced electro-
physiology group with more than 100 AF ablation proce-
dures per year and published results.7
We conclude that minimally invasive pulmonary vein iso-
lation is successful in controlling paroxysmal AF no matter
whether previous multiple unsuccessful catheter ablations
have been performed. The cause of percutaneous catheter
ablation failure may be due to a lack of pulmonary vein iso-
lation. On the other hand, thoracoscopy-assisted pulmonary
vein isolation did not provide efficient control of persistent
AF and failed to control long-standing persistent AF, prob-
ably owing to an alteration in the atrial substrate that over-
rides the importance of the triggering zones around
pulmonary veins. Last, the technical procedure was feasible
and reproducible, although as with other minimally invasive
surgical operations, there is a learning curve that needs to be
confronted.References
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